CLOFENCICLAN HYDROCHLORIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H28ClNO.ClH
Molecular Weight	346.335
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CCN(CC)CCOC1(CCCCC1)C2=CC=C(Cl)C=C2

InChI

InChIKey=GHTNEJJXVUMOPX-UHFFFAOYSA-N

InChI=1S/C18H28ClNO.ClH/c1-3-20(4-2)14-15-21-18(12-6-5-7-13-18)16-8-10-17(19)11-9-16;/h8-11H,3-7,12-15H2,1-2H3;1H

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C18H28ClNO
Molecular Weight	309.874
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://patents.google.com/patent/US3254083A/en | https://link.springer.com/article/10.1007%2FBF00245072

Clofenciclan is a dopamine-releasing agent, developed by Boehringer & Soehne in the 1950s for the treatment of Parkinson's disease. Compared to other anti-parkinsonian drugs of the time, clofenciclan lacked peripheral anticholinergic properties and caused pronounced stimulation of the central nervous system.

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:48:52 GMT 2025` Edited by `admin` on `Mon Mar 31 18:48:52 GMT 2025`
Record UNII	8FR9OY53P6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CLOFENCICLAN HYDROCHLORIDE

Common Name

English

2-((1-(P-CHLOROPHENYL)CYCLOHEXYL)OXY)TRIETHYLAMINE HYDROCHLORIDE

Preferred Name

English

Clofenciclan hydrochloride [WHO-DD]

Common Name

English

ETHANAMINE, 2-((1-(4-CHLOROPHENYL)CYCLOHEXYL)OXY)-N,N-DIETHYL-, HYDROCHLORIDE (1:1)

Systematic Name

English

CLOFENCICLAN HCL

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID80928172